PDE4A and Sepsis: PDE4 inhibitors stabilize both the endothelial cells and pulmonary epithelium, and thereby reduce the sepsis- and inflammation-induced elevation in a microvascular permeability [142], as it has been demonstrated in several animal in vivo studies.